6,029 filings
Page 10 of 100
6-K
GSK
GSK Plc
17 Apr 23
Director/pdmr Shareholding
10:54am
6-K
GSK
GSK Plc
17 Apr 23
Gepotidacin Positive Phase III Data
6:26am
20-F/A
2022 FY
GSK
GSK Plc
17 Apr 23
Annual report (foreign) (amended)
12:00am
6-K
GSK
GSK Plc
3 Apr 23
Total Voting Rights
8:10am
6-K
GSK
GSK Plc
28 Mar 23
Positive Phase III Ruby Results for Jemperli
8:00am
6-K
GSK
GSK Plc
27 Mar 23
Publication of 2023 Agm Notice
8:51am
6-K
GSK
GSK Plc
24 Mar 23
Statement: Zantac (Ranitidine) Litigation
8:29am
6-K
GSK
GSK Plc
21 Mar 23
Director/pdmr Shareholding
11:36am
6-K
GSK
GSK Plc
20 Mar 23
Director/pdmr Shareholding
11:41am
EFFECT
Glaxosmithkline Capital Inc
16 Mar 23
Notice of effectiveness
12:15am
6-K
GSK
GSK Plc
14 Mar 23
Positive Phase III Results for Menabcwy Vaccine
7:11am
6-K
GSK
GSK Plc
14 Mar 23
Nucala Nda Accepted for Review In China
7:04am
6-K
GSK
GSK Plc
13 Mar 23
Director/pdmr Shareholding
11:39am
POS AM
Glaxosmithkline Capital Inc
10 Mar 23
Prospectus update (post-effective amendment)
12:20pm
6-K
GSK
GSK Plc
10 Mar 23
GSK Annual Report 2022 on Form 20-F
12:16pm
IRAN
GSK
GSK Plc
10 Mar 23
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
11:22am
20-F
2022 FY
GSK
GSK Plc
Annual report (foreign)
10 Mar 23
11:13am
6-K
GSK
GSK Plc
10 Mar 23
GSK Publishes Annual Report 2022
6:53am
6-K
GSK
GSK Plc
2 Mar 23
Fda Ad Com Votes to Support GSK RSV Oa Vaccine
6:33am
6-K
GSK
GSK Plc
1 Mar 23
Total Voting Rights
12:05pm